The BNT162b2 KP.2 vaccine effectively prevents severe COVID-19 outcomes, including hospitalizations and ED or UC visits.

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Adam Grippin, The University of Texas MD Anderson Cancer Center and Christiano Marconi ...

A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...

COVID-19 mRNA vaccines create enough of an immunity boost to extend survival in certain types of lung and skin cancers, an analysis of more than 1,000 patient files showed. The scientific journal ...

Why are vaccines so hard to make? The fda approved two mRNA vaccines for COVID-19, but it was a challenge to make this type of vaccine work. In fact, it took decades of research to get us to the point ...

Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology ...

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...

In a blast from the past, COVID-19 vaccine developer Moderna (NASDAQ: MRNA) just made headlines in 2026. Shares jumped up ...